FULCRUM THERAPEUTICS, INC. Treasury Stock, Value
FULCRUM THERAPEUTICS, INC. (FULC) had Treasury Stock, Value of $0 as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Balance Sheet
us-gaap:TreasuryStockValue · last filed 2023-08-03
- 2023-06-30: Treasury Stock, Value $0.00.
- 2023-03-31: Treasury Stock, Value $0.00.
- 2022-12-31: Treasury Stock, Value $0.00.
- 2022-09-30: Treasury Stock, Value $0.00.
| Period end | Treasury Stock, Value |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-03 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 |
| 2021-12-31 | $0.00 10-K/A · filed 2023-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |